deltatrials
Not Yet Recruiting NA INTERVENTIONAL 1-arm NCT06915402

Efficacy and Safety of LMW - CL - HA - FACE/BODY for the Augmentation of the Cheeks (RF-HA-FB-2024)

A Post-market, Interventional, Confirmative Clinical Investigation to Evaluate the Performance and the Safety of LMW - CL - HA - FACE/BODY Used as Intended for the Restoration of the Physiological Volumes of the Cheeks

Sponsor: Rose Pharma SA

Conditions Esthetics
Updated 1 time since 2025 Last updated: Apr 3, 2025 Started: Apr 1, 2025 Primary completion: Dec 31, 2025 Completion: Dec 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Esthetics and is currently actively recruiting participants. Rose Pharma SA leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~May 2025 – present · 14 months · monthly snapshotNot Yet Recruiting

Change History

1 version recorded
Not Yet Recruiting — NA [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Rose Pharma SA
Data source: Rose Pharma SA

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.